NEXGEL, Inc. (NASDAQ:NXGLW) Sees Significant Decline in Short Interest

NEXGEL, Inc. (NASDAQ:NXGLW) was the recipient of a large drop in short interest in January. As of January 30th, there was short interest totaling 1,621 shares, a drop of 69.2% from the January 15th total of 5,271 shares. Based on an average daily volume of 1,910 shares, the short-interest ratio is currently 0.8 days. Based on an average daily volume of 1,910 shares, the short-interest ratio is currently 0.8 days.

NEXGEL Price Performance

Shares of NXGLW traded down $0.00 during mid-day trading on Thursday, hitting $0.17. 5,762 shares of the company traded hands, compared to its average volume of 3,897. The business has a 50-day moving average of $0.19 and a 200 day moving average of $0.26. NEXGEL has a one year low of $0.10 and a one year high of $1.33.

About NEXGEL

NEXGEL, Inc manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments, Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications under the MedaGel brand; and beauty and cosmetic solutions, such as wrinkle and skin cream applications under the LumaGel Beauty brand name.